Published in Cancer Weekly, June 2nd, 2009
"The relatively high frequency of such variants means that they could potentially explain a substantial portion of disease risk. Here we summarize the findings published to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.